Search

Your search keyword '"Mast-Cell Sarcoma drug therapy"' showing total 5 results
Start Over Descriptor "Mast-Cell Sarcoma drug therapy" Publisher pergamon press
5 results on '"Mast-Cell Sarcoma drug therapy"'

1. Effect of carcinogen ethionine on enzymatic methylation of DNA sequences with various degrees of repetitiveness.

Author

Boehm TL and Drahovsky D

Subjects
Animals, Base Sequence, Mast-Cell Sarcoma drug therapy, Methylation, Mice, Mice, Inbred Strains, Sarcoma, Experimental metabolism, DNA (Cytosine-5-)-Methyltransferases antagonists & inhibitors, DNA, Neoplasm metabolism, Ethionine pharmacology, Mast-Cell Sarcoma metabolism, Methyltransferases antagonists & inhibitors
Published
1979
Full Text
View/download PDF

2. Suppressor T cells and the regression phase of syngeneic intradermally developing p-815 mastocytomas.

Author

Bertschmann M, Schären B, and Lüscher EF

Subjects
Animals, Cyclophosphamide therapeutic use, Dose-Response Relationship, Drug, Female, Immunization, Passive, Mast-Cell Sarcoma drug therapy, Mice, Mice, Inbred DBA, Neoplasms, Experimental immunology, Mast-Cell Sarcoma immunology, T-Lymphocytes, Regulatory immunology
Abstract

Thymus cells obtained 6, 8 or 10 days after the intradermal injection of P-815 tumor cells into syngeneic DBA/2 mice were, upon adoptive transfer into new hosts, incapable of abrogating the normally observed tumor regression phase. Transfer of cells from day 8 revealed a tendency toward suppression of regression phases; cells from day 6 or 10 were inert or had a rather immunopotentiating effect. Pretreatment of tumor hosts with cyclophosphamide did not result in more pronounced regression phases, nor did this treatment raise the percentage of surviving animals. Injection of cyclophosphamide after tumor cell inoculation resulted in a slight delay of tumor growth, but not in more pronounced regression nor in higher survival rates. Taken together the data suggest that in a weakly immunogenic and highly malignant tumor, suppressor T cells may play a minor role in the subversion of the host's immune response.

Published
1982
Full Text
View/download PDF

3. Cytostatic activity of chlamydocin, a rapidly inactivated cyclic tetrapeptide.

Author

Stähelin H and Trippmacher A

Subjects
Animals, Antibiotics, Antineoplastic administration & dosage, Antibiotics, Antineoplastic toxicity, Carcinoma 256, Walker drug therapy, Carcinoma, Ehrlich Tumor drug therapy, Cell Count, Cell Division drug effects, Ethers, Cyclic administration & dosage, Ethers, Cyclic toxicity, Hot Temperature, In Vitro Techniques, Injections, Intra-Arterial, Injections, Intraperitoneal, Injections, Intravenous, Lethal Dose 50, Leukemia L1210 drug therapy, Mast-Cell Sarcoma drug therapy, Mice, Peptides, Cyclic administration & dosage, Peptides, Cyclic toxicity, Rats, Antibiotics, Antineoplastic therapeutic use, Ethers, Cyclic therapeutic use, Neoplasms, Experimental drug therapy, Peptides, Cyclic therapeutic use
Published
1974
Full Text
View/download PDF

4. 4'-Demethyl-epipodophyllotoxin thenylidene glucoside (VM 26), a podophyllum compound with a new mechanism of action.

Author

Stähelin H

Subjects
Animals, Carcinoma 256, Walker drug therapy, Culture Techniques, Female, Fibroblasts drug effects, Leukemia L1210, Male, Mast-Cell Sarcoma drug therapy, Mice, Phytotherapy, Podophyllum therapeutic use, Rats, Mitosis drug effects, Neoplasms, Experimental drug therapy, Plants, Medicinal, Plants, Toxic, Podophyllum pharmacology
Published
1970
Full Text
View/download PDF

5. Suppression of growth of P-815 mastocytoma cells in vitro by drugs increasing cellular cyclic 3',5'-adenosine monophosphate.

Author

Keller R and Keist R

Subjects
Agglutination Tests, Animals, Cell Count, Cell Division, Cell Line, Concanavalin A, Cyclic AMP analysis, Cyclic AMP pharmacology, Epinephrine pharmacology, Histamine pharmacology, In Vitro Techniques, Isoproterenol pharmacology, Mice, Mitosis, Neoplasm Transplantation, Radioimmunoassay, Serotonin pharmacology, Theophylline pharmacology, Thymidine metabolism, Tritium, Cyclic AMP metabolism, Mast-Cell Sarcoma drug therapy
Published
1973
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results